GNMX - Aevi Genomic Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development22,29925,17628,35615,444
Selling General and Administrative8,6639,52412,55312,954
Non Recurring----
Total Operating Expenses30,96234,70040,90928,398
Operating Income or Loss-30,962-34,700-40,909-28,398
Income from Continuing Operations
Total Other Income/Expenses Net187-14-979-9,577
Earnings Before Interest and Taxes-30,962-34,700-40,909-28,398
Interest Expense--34-9-1
Income Before Tax-30,775-34,714-41,888-37,975
Income Tax Expense--1617
Minority Interest----
Net Income From Continuing Ops-30,775-34,714-41,904-37,992
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-30,775-34,714-41,904-37,992
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-30,775-34,714-41,904-37,992